Session Detail


Session Number: 2604
Session Title: Food Allergy
Session Type: Oral Abstract Session
Location: Convention Center, S230CD, Level II
Session Start: 3/3/2012 2:00:00 PM
Session End: 3/3/2012 3:15:00 PM
CE Units: 1.50
CME Credits: 1.25
Program #: 245 - 249
Moderators:
Pamela A. Frischmeyer-Guerrerio, MD PhD
Antonella M. Muraro, PhD
Presentations:
Saturday, Mar 03, 2012, 2:00 PM - 2:15 PM
 245. A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Egg Oral Immunotherapy in Children: An Analysis of Clinical Tolerance
 S. M. Jones1, A. W. Burks2, R. A. Wood3, D. M. Fleischer4, S. H. Sicherer5, R. W. Lindblad6, D. Stablein6, A. K. Henning6, B. P. Vickery2, A. H. Liu4, A. M. Scurlock1, W. G. Shreffler7, M. Plaut8, H. A. Sampson5;
1University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, AR, 2Duke University Medical Center, Durham, NC, 3Johns Hopkins Unviversity Medical Center, Baltimore, MD, 4National Jewish Health, Denver, CO, 5Mount Sinai School of Medicine, New York, NY, 6The EMMES Corporation, Rockville, MD, 7Massachusetts General Hospital, Harvard Medical School, Boston, MA, 8National Institutes of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD.
Saturday, Mar 03, 2012, 2:15 PM - 2:30 PM
 246. Peanut Challenge Outcomes Following Sublingual Immunotherapy (SLIT) Correlate With Increased Peanut-Specific Salivary IgA
 M. D. Kulis, K. Saba, E. H. Kim, J. A. Bird, N. Kamilaris, B. P. Vickery, H. Staats, A. W. Burks;
Duke University Medical Center, Durham, NC.
Saturday, Mar 03, 2012, 2:30 PM - 2:45 PM
 247. Plasma from Subjects on Peanut Oral Immunotherapy (OIT) Suppresses ex vivo Basophil Activation in Peanut-Allergic Subjects
 C. Burk, M. Kulis, N. Kamilaris, S. Chin, A. W. Burks;
Duke University Medical Center, Durham, NC.
Saturday, Mar 03, 2012, 2:45 PM - 3:00 PM
 248. Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial (CoFAR)
 D. M. Fleischer1, R. A. Wood2, S. M. Jones3, S. H. Sicherer4, A. H. Liu1, D. Stablein5, A. Henning5, L. Mayer4, R. Lindblad5, H. A. Sampson4, A. W. Burks6;
1National Jewish Health, Denver, CO, 2Johns Hopkins University Medical Center, Baltimore, MD, 3University of Arkansas for Medical Sciences and Arkansas Childrens Hospital, Little Rock, AR, 4Mount Sinai School of Medicine, New York, NY, 5The EMMES Corporation, Rockville, MD, 6Duke University Medical Center, Durham, NC.
Saturday, Mar 03, 2012, 3:00 PM - 3:15 PM
 249. Development of Clinical Tolerance after Peanut OIT
 A. W. Burks1, B. P. Vickery1, A. M. Scurlock2, P. Steele1, J. Kamilaris1, A. M. Hiegel2, S. K. Carlisle2, T. T. Perry2, S. M. Jones2;
1Duke University Medical Center, Durham, NC, 2University of Arkansas for Medical Sciences, Little Rock, AR.
 
American Academy of Allergy Asthma & Immunology
555 East Wells Street
Milwaukee, WI 53202-3823
(414) 272-6071
annualmeeting@aaaai.org